CCR5 and colorectal carcinoma: Interestingly, CCR5 was significantly upregulated in both SW620 and NCM460 cells after the treatment with rBFT1, indicating that CCL3 and its receptor CCR5 may mediate the roles of rBFT1 or ETBF in the proliferation of CRC.